Stealth BioTherapeutics Corp.’s shares crashed after the company’s lead neuromuscular disorder product candidate failed to help patients walk better and reduce fatigue.
Apple Inc. launched an app that will let users of the company’s devices to enroll in three health studies, allowing them to share health-related data for medical research.
The world economy could be boosted by as much as $100 billion a year if employers successfully encouraged their staff to meet World Health Organization guidelines on exercise, according to an analysis of the economic impact of activity.
The U.S. Supreme Court declined to hear Acorda Therapeutics Inc.’s appeal of a lower court ruling that allowed generic versions of the company’s multiple sclerosis treatment Ampyra.
People who get even a small amount of exercise may be less likely to die prematurely than their more sedentary counterparts, a research review suggests.
Obese people who engaged in resistance training were more likely to see reductions in a type of heart fat, a new study finds.
Older adults with slightly elevated blood sugar – sometimes called “prediabetes” – usually do not develop full-blown diabetes, a Swedish study suggests.
People who track their daily steps may not only be more active, they may also be less likely to develop health problems that lead to events like heart attacks or broken bones, a new study suggests.
Gelesis announced that the United States Food and Drug Administration cleared the biotechnology company’s lead product candidate Plenity (Gelesis100) as an aid in weight management in adults with a Body Mass Index (BMI) of 25–40 kg/m2, when used in conjunction with diet and exercise.
Taking caffeine before exercise could improve performance during a broad range of exercise tasks, according to a new review of past research.
